During drug therapy with epoetin alfa (Epogen), the nurse knows that therapy must be stopped if which laboratory result is noted?

Question

Quizplus · Accepted Answer

When hemoglobin levels are above 12 g/dL and the epoetin alfa is continued, patients may experience serious adverse events, including heart attack, stroke, and death. Epoetin must not be given to patients with renal disorders unless their hemoglobin level is less than 12 g/dL. In cancer patients, the hemoglobin level needs to be less than 10 g/dL. The other options are incorrect.

During Drug Therapy with Epoetin Alfa (Epogen), the Nurse Knows